China's Spending for Drugs to Rise 6-9% during 2016-2020: IMS

Over the next five years, China's spending on medicines will grow at a 6-9% CAGR, with a total drug spend of $150-$180 billion in 2020, according to a forecast released by healthcare consultancy IMS. Just one year ago, IMS predicted that China's drug market would grow at a 10-13% CAGR over the same time period. China's expected economic slowdown is part of the reason for the revision, says IMS, but the healthcare specialist also thinks most of China's citizens already have access to medicines, reducing the possibility for future growth. More details.... Share this with colleagues: // //